Filing Details

Accession Number:
0001179110-17-002012
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-02-09 09:48:37
Reporting Period:
2017-02-08
Filing Date:
2017-02-09
Accepted Time:
2017-02-09 09:48:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
896264 Usana Health Sciences Inc USNA Medicinal Chemicals & Botanical Products (2833) 870500306
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1636301 Ltd Global Gull Po Box N-4899, 2/F Bahamas Financial Ctr
Shirley &Amp; Charlotte Streets
Nassau C5 BH1-1000
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-02-08 20,000 $55.87 12,558,220 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The holder of record of the shares of Common Stock disposed is Gull Global Limited, an entity wholly indirectly owned and controlled by Dr. Myron W. Wentz.
  2. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 18, 2015.
  3. Weighted average price. Price range in multiple transactions was $54.60 to $58.10, inclusive. The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff at the Securities and Exchange Commission information regarding the number of shares sold at each price within the ranges set forth.